Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O R Eshmatov"'
Publikováno v:
Байкальский медицинский журнал, Vol 2, Iss 3, Pp 19-20 (2023)
BACKGROUNDIt is known that the autonomic nervous system plays a significant role in the onset, maintenance and arrest of atrial fibrillation. Its influence is determined by a combination of direct and indirect effects on the special conductive ca
Externí odkaz:
https://doaj.org/article/326f1939c8b04b0abc9ea1da03ae6c5a
Autor:
E. A. Archakov, R. E. Batalov, M. S. Khlynin, M. A. Dragunova, E. S. Sitkova, O. R. Eshmatov, T. V. Moskovskikh, S. Yu. Usenkov, I. V. Stepanov, S. A. Afanasyev, S. V. Popov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 409-417 (2024)
Aim. To assess the incidence of chronic myocarditis in patients with atrial fibrillation.Material and methods. The study included 145 patients. The majority of patients were male — 118 (81.4%). The median age was 45 (38; 50) years. Most had paroxys
Externí odkaz:
https://doaj.org/article/533527ab1a574b53a507d865cf156514
Autor:
O. R. Eshmatov, R. E. Batalov, S. N. Krivolapov, M. S. Khynin, E. S. Sitkova, L. A. Pokrovskaya, E. M. Berezina, V. V. Botvin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 77-84 (2024)
Infections associated with cardiac implantable electronic devices (CIED) pose a serious risk to the patient’s health due to the high mortality rate of this type of complications. This literature review presents risk factors, microbiology and pathog
Externí odkaz:
https://doaj.org/article/996b566916fc43fbadd03fb522387d24
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 160-166 (2023)
Aim. To study the efficacy and safety of antithrombotic therapy in patients with paroxysmal atrial fibrillation (AF) after catheter treatment during 36 months of follow-up.Material and methods. The retrospective observational study included 592 patie
Externí odkaz:
https://doaj.org/article/e624532c236548418c9faceb1ab17edd
Publikováno v:
Journal of Arrhythmology. 28:21-27
Aim. To study the efficacy and safety of anticoagulant therapy in patients with persistent atrial fibrillation (AF) after interventional treatment during 36 months of follow-up.Material and methods. The study included 135 patients (78 men and 58 wome
Publikováno v:
Kardiologiia. 62(8)
Aim To evaluate efficacy and safety of the anticoagulant therapy in patients with atrial fibrillation (AF) during a 36-month follow-up after an interventional treatment.Material and methods This study included 302 patients aged 29 to 81 years with va